Aspen Aerogels (NYSE:ASPN) Stock Rating Upgraded by StockNews.com

Aspen Aerogels (NYSE:ASPN) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a note issued to investors on Wednesday.

Several other research analysts have also recently issued reports on ASPN. HC Wainwright reaffirmed a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. Roth Mkm reduced their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a research note on Friday, November 8th. Benchmark restated a “buy” rating and set a $14.00 target price on shares of Aspen Aerogels in a research report on Thursday, August 8th. Piper Sandler cut their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Finally, TD Cowen lifted their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. One analyst has rated the stock with a sell rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $28.70.

Aspen Aerogels Stock Down 2.7 %

Shares of NYSE ASPN opened at $15.12 on Wednesday. The firm’s fifty day moving average is $22.44 and its 200 day moving average is $24.67. Aspen Aerogels has a 52 week low of $9.89 and a 52 week high of $33.15. The company has a market cap of $1.24 billion, a price-to-earnings ratio of 1,553.55 and a beta of 2.21. The company has a quick ratio of 2.82, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Insiders Place Their Bets

In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the completion of the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. This trade represents a 11.58 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. The trade was a 60.96 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. Point72 Hong Kong Ltd acquired a new stake in shares of Aspen Aerogels during the 2nd quarter worth about $84,000. nVerses Capital LLC acquired a new position in Aspen Aerogels in the 2nd quarter valued at $95,000. Quent Capital LLC purchased a new position in shares of Aspen Aerogels during the 3rd quarter worth $118,000. Point72 DIFC Ltd acquired a new stake in shares of Aspen Aerogels during the second quarter worth $121,000. Finally, Public Employees Retirement Association of Colorado acquired a new position in Aspen Aerogels in the second quarter valued at $145,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.